EGFR and neoplasm: In such a scenario, it is possible that oncogenic ErbB/MHC signaling would be particularly impactful since MHCI expression on tumor cells would be effectively dependent on cytokines present in the tumor microenvironment for MHCI expression yet rendered less responsive to cytokines due to aberrant ErbB/HER signaling.